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Abstract 
The suppressor of cytokine signalling protein 3 (SOCS3) critically controls immune cell 
activation, although its role in macrophage polarization and function remains controversial. Using 
experimental autoimmune uveoretinitis (EAU) as a model, we show that inflammation-mediated 
retinal degeneration is exaggerated and retinal angiogenesis is accelerated in mice with SOCS3 
deficiency in myeloid cells (LysMCre/+SOCS3fl/fl). At the acute stage of EAU, the population of 
infiltrating neutrophils was increased and the population of macrophages decreased in 
LysMCre/+SOCS3fl/fl mice compared to that in WT mice. Real-time reverse transcription-PCR 
showed that the expression of tumor necrosis factor-α, IL-1β, interferon-γ, 
granulocyte-macrophage colony-stimulating factor, and Arginase-1 was significantly higher in the 
LysMCre/+SOCS3fl/fl EAU retina in contrast to WT EAU retina. The percentage of Arginase-1+ 
infiltrating cells was significantly higher in the LysMCre/+SOCS3fl/fl EAU retina than that in the 
WT EAU retina. In addition, bone-marrow–derived macrophages and neutrophils from the 
LysMCre/+SOCS3fl/fl mice express significantly higher levels of CCL2 and Arginase-1 compared 
to those from WT mice. Inhibition of Arginase using an L-arginine analog 
amino-2-borono-6-hexanoic suppressed inflammation-induced retinal angiogenesis without 
affecting the severity of inflammation. Our results suggest that SOCS3 critically controls the 
phenotype and function of macrophages and neutrophils under inflammatory conditions and loss 
of SOCS3 promotes the angiogenic phenotype of the cells through up-regulation of Arginase-1.  
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Introduction 
Inflammation-induced angiogenesis is involved in many pathological conditions, including 
cancer and autoimmune diseases[1-3]. Although the management of angiogenic diseases has been 
revolutionized over the past decade with the use of VEGF inhibitors[4-6], they remain a major 
challenge in modern medical care. Previously we reported that chronic inflammation in 
experimental autoimmune uveoretinitis (EAU) induces retinal angiogenesis[7], a condition 
mirroring retinal neovascular membrane (RNM) secondary to long-standing posterior segment 
intraocular inflammation[8] or retinal angiomatous proliferation in age-related macular 
degeneration[9]. It was further shown that CCR2+ macrophages are critically involved in 
EAU-induced retinal angiogenesis[7, 10], although the underlying mechanism remains poorly 
defined.  
The EAU retina is characterized by a diverse immune cell infiltrate, including macrophages, 
neutrophils, dendritic cells, CD4 and CD8 T cells, B cells, and myeloid-derived suppressor cells 
(MDSC) [10]. The constitution of different subsets of infiltrating cells differs at different stages of 
EAU. For example, macrophages and neutrophils constitute 40% and 10% of retinal infiltrating 
cells during acute EAU (ie, day 25 post-immunization (p.i.)), and are reduced to 19% and 1%, 
respectively, during latter chronic stages of EAU[10]. On the other hand, the percentage of CD8 T 
cells, CD11c dendritic cells, and MDSCs increased from the acute stage to the chronic stage[10]. 
Furthermore, a dynamic change in the phenotype of the infiltrating cells in different stages of 
EAU was also observed. For instance, the majority of macrophages were found to be CD68+ 
(proinflammatory phenotype) during the acute stages, whereas at the chronic (angiogenic) stages, 
over half of the infiltrating F4/80 macrophages were found to be Arginase-1+ (wound-healing 
phenotype)[7]. These results suggest that the microenvironment of the inflamed retina not only 
controls the type of circulating immune cells to be recruited but also determines the phenotype 
and function of infiltrating cells.   
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CCL2/CCR2 but not CX3CL1/CX3CR1 pathway is critically involved in the trafficking of 
monocytes across the blood retinal barrier in EAU[11], although in the absence of the CCL2/CCR2 
pathway, neutrophils can infiltrate the retina and induce inflammation. In the inflamed retina, 
infiltrating immune cells respond to environmental cues through cell surface receptors and 
differentiate into different types of effector cells. The JAK/STAT pathways are critically involved 
in many cytokine receptor signalling cascades[12]. Although, there are only four known JAKs and 
seven STATs, collectively they control over 40 cytokine receptor signalling [12, 13]. The 
JAK1,2/STAT3 is known to be important for the transduction and transcription of cytokines 
involved in proliferation and angiogenesis such as IL-6, vascular endothelial growth factor 
(VEGF), epidermal growth factors, and granulocyte-macrophage colony-stimulating factor 
(GM-CSF)[12, 14, 15]. The SOCS proteins negatively regulate the JAK/STAT pathways through 
association with key phosphorylated tyrosine residues on JAK and/or cytokine receptors[16]. 
SOCS3 critically control the JAK1,2/STAT3 pathway [17-19]. The role of SOCS3 in macrophage 
polarization and function remains controversial[20, 21].  
This study aimed to understand the role of SOCS3 in myeloid cell activation and function in the 
context of EAU. We show that EAU-induced retinal degeneration was exaggerated and 
angiogenesis was accelerated in the myeloid-cell–specific SOCS3 deficient mice (ie, 
LysMCre/+SOCS3fl/fl mice). Further mechanistic studies highlighted that deletion of SOCS3 led to 
increased Arginase-1 (Arg-1) and CCL2 expression in both macrophages and neutrophils.  
 
Materials and Methods 
Mice and induction of experimental autoimmune uveoretinitis 
Eight- to 12-week–old C57BL/6J, SOCS3fl/fl, and LysMCre/+SOCS3fl/fl mice (both in C57BL/6J 
background) were used in the study. The LysMCre/+SOCS3fl/fl mice were obtained by 
crossbreeding the SOCS3fl/fl mice and the LysM-Cre mice. The absence of SOCS3 in myeloid 
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cells in the LysMCre/+SOCS3fl/fl mice was confirmed by Western blotting of peritoneal 
macrophages. The SOCS3fl/fl mice were used as controls in some experiments. All mice were 
maintained in the Biological Research Unit at Queen’s University Belfast and exposed to 
12h-light/12-night cycle with free access to water and food. All procedures were conducted under 
the regulation of the UK Home Office Animals (Scientific Procedures) Act 1986, and approved 
by the Animal Welfare & Ethical Review Body of Queen’s University Belfast. 
EAU was induced in mice using a protocol described previously [22, 23]. Briefly, mice were 
immunized with 500 µg IRBP1-20 (GPTHLFQPSLVLDMAKVLLD, GL Biochem, Shanghai, 
China), emulsified 1:1 in complete Freund’s adjuvant (DIFCO Laboratories, Detroit, MI), and 
supplemented with 2.5mg/mL Mycobacterium tuberculosis H37Ra (DIFCO Laboratories). An 
additional 1µg of Bordetella pertussis toxin (Tocris Bioscience, Bristol, UK) was administered i.p. 
immediately after immunization injection.  
Clinical assessment of retinal inflammation 
Retinal inflammation was assessed clinically at different days post-immunization (p.i.) by the 
Topical Endoscopic Fundus Imaging system and scored using the criteria described previously[24]. 
The animals were anaesthetized using isoflurane (Merial Animal Health Ltd., Essex, UK), and 
pupils were dilated with 1% atropine sulphate and 2.5% phenylephrine hydrochloride (Chauvin, 
Essex, UK). Fundus images were captured by Nikon D90 camera via an endoscope and saved in 
TIF format. The inflammation score is based on i) the number and size of retinal infiltrates, ii) the 
severity of optic disc swelling, and iii) the severity and number of vascular cuffing[24]. Whereas 
the structural damage score is based on the area of retinal lesion or atrophy and the number of 
linear lesion[24]. Inflammation and structure damage scores were analyzed separately. 
Fundus fluorescein angiography (FFA) was conducted by intraperitoneal injection of 100µL 10% 
sodium fluorescein to mice. The FFA images were recorded within 5 mins using the SpectralisTM 
HRA2 confocal scanning laser ophthalmoscope (Heidelberg Engineering Ltd., Hertfordshire, 
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UK). Four images were taken from different regions of the fundus in each eye. The number of 
localized hyper-fluorescence lesions in each eye were manually counted using the FFA images. 
Spectral domain-optical coherence tomography (SD-OCT) imaging 
Mice were anaesthetized with Ketamine (Vetoquinol UK Ltd., Buckingham, UK) and Rompun 
(Bayer Health Care, Kiel, Germany) via intraperitoneal injection. Pupils were dilated as described 
above. Viscotears Liquid Gel (Novartis Pharmaceuticals Ltd., Surrey, UK) was used to moisture 
the ocular surface. OCT scans (30º field of view) were conducted using the SD-OCT system 
(Heidelberg Engineering Ltd., Hertfordshire, UK). Neuroretinal thickness (from nerve fiber layer 
to RPE) was measured 1000µm distance away from the optical disc at four quadrants. 
In vivo treatment 
WT EAU mice were administered intraperitoneally with the arginase inhibitor, 
amino-2-borono-6-hexanoic acid (ABH, 200µM, Cayman Chemical Company, MI) once daily 
from day 60 to day 79 p.i. The LysMCre/+SOCS3fl/fl EAU mice were treated with 200 µM ABH 
from day 14 to day 59 p.i. Clinical and histological examination was conducted at the end of 
treatment. The control EAU group received 100 µL PBS injections. 
Histopathology 
Mouse eyes were fixed in 2.5% (w/v) glutaraldehyde (Agar Scientific Ltd., Stansted, UK) for 24h, 
then embedded in paraffin and processed for H&E staining. Sections from four layers, 100µm 
apart were studied in each eye and the severity of EAU was graded according to the criteria 
described previously [25]. 
Immunofluorescence of Retinal whole-mounts or sections 
Mouse eyes were fixed with 2% paraformaldehyde (Agar Scientific Ltd.) at room temperature for 
2h. The retinas were dissected and permeabilized with 0.3% Triton X-100 (Sigma-Aldrich, 
Dorset, UK) in PBS for 6h. The samples were then incubated with rabbit anti-mouse collagen IV 
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(AbD Serotec, Kidlington, UK), or rat anti-mouse CD45 (BD Biosciences, Oxford, UK) and 
rabbit anti-arginase-1 (Santa Cruz, Heidelberg, Germany) at 4 oC overnight, followed by 
incubating with Alexa Fluor 546–conjugated donkey anti-rabbit IgG or Alexa Fluo 488–
conjugated donkey anti-rat IgG (Life Technologies Ltd, Paisley, UK) for 3h. After thorough 
washes, samples were mounted on glass slides with Vectashield mounting medium (Vector 
Laboratories, Burlingame, CA).  
Retinal cryosections (6µm thickness) were fixed with 2% paraformaldehyde for 30 minutes. 
Samples were blocked with 10% bovine serum albumin (BSA), followed by incubation with 
anti-mouse collagen IV (AbD Serotec) and rat anti-mouse CD105 (Bio-Red Laboratories Led, 
Watford, UK) for 2h. After thorough washes, samples were incubated with Alexa Fluor 488–
conjugated donkey anti-rabbit IgG and Alexa Fluor 546–conjugated goat anti-rat IgG (Life 
Technologies Ltd) for 1h. All samples were examined by confocal microscopy (Eclipse TE200-U, 
Nikon UK Ltd, Surry, UK). 
Cell culture 
Bone-marrow–derived macrophages (BMDMs) 
Bone marrows were flushed from the tibia and femur of WT and LysMCre/+SOCS3fl/fl mice. Red 
blood cells were removed with lysis buffer. The cells were then cultured in DMEM (Gibco BRL, 
Paisley, UK) supplemented with 10% FCS and 15% L929 conditioned medium and 100µg/mL 
Primocin (InvivoGen, San Diego, CA) at 37 °C for seven days. The BMDMs were harvested and 
phenotype confirmed by flow cytometry (>95% CD11b+F4/80+). The BMDMs were further 
stimulated overnight with 100ng/mL IFN-γ (R&D Systems, Abingdon, UK) + 50ng/mL LPS 
(Sigma-Aldrich) for M1 activation or with 20ng/mL IL-4 (R&D Systems) for M2 activation [26].  
Bone marrow neutrophils 
Neutrophils were purified from the bone marrow of SOCS3fl/fl and LysMCre/+SOCS3fl/fl mice 
using a Neutrophil Isolation Kit (Miltenyi Biotec, Bisley, UK) and confirmed to be >90% Ly6G+. 
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Total RNAs were isolated from the cells and further processed for real-time reverse 
transcription-PCR analysis of immune-related genes.  
Neutrophil oxidative burst assay 
Fresh isolated bone marrow neutrophils (1x105) from WT and LysM-Cre:SOCS3fl/fl mice were 
mixed with 50µg/mL dihydrorhodamine (DHR) 123 (Life Technologies) in 200µL RPMI1640 
supplemented with 10% FCS and 100µg/mL Primocin (InvivoGen) in FACS tubes at 37 ºC for 
20mins. The reaction was stopped by cooling samples on ice for 10min.  Rhodamine generated 
from DHR123 by reactive oxygen species was examined by flow cytometry (BD FACSCantoII, 
BD Biosciences). The data were analyzed by FlowJo Software (TreeStar Inc., OR). 
Neutrophil phagocytosis assay 
Fresh isolated bone marrow neutrophils (5x104) were mixed with 1x106 FITC-conjugated E.coli 
particles in 1mL RPMI1640 supplemented with 10% FCS and 100µg/mL Primocin (InvivoGen) 
in FACS tubes and incubated at 37 ºC for 2 hr or 24 hr. Samples were rapidly chilled on ice, and 
free E.coli particles were washed away by ice-cold PBS. Samples incubated at 4 ºC were used as 
background controls. Samples were examined by BD FACSCantoII (BD Biosciences). The data 
were analyzed by FlowJo Software (TreeStar Inc., OR). 
Flow cytometry 
Retinal single cell preparation 
The retinas were dissected and treated with 1 mg/mL collagenase I (Sigma-Aldrich) at 37 oC for 
30mins. The single cell suspension was washed and filtered through a 100 µm cell strainer (BD 
Biosciences). The cell suspension from one retina was used for each flow cytometry analysis. 
Preparation of cells from blood and spleen  
Mouse whole blood were collected in heparinized tubes and 30µL were used for FACS staining. 
The spleen was homogenized and single cell suspension was obtained by passing samples 
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through a 100µm cell strainer (BD Labware, Oxford, UK). Red blood cells were removed with 
lysis buffer and 2x105 splenocytes were used for FACS staining. 
Preparation of cells from in vitro cultures  
The cells were dissociated by incubation in cold PBS followed by scraping and flushing. Cell 
aggregates were dissociated and single cell suspension was obtained by passing the samples 
through a cell strainer (100µm). 2 × 105 cells were used for each FACS staining. 
FACS staining, acquisition, and analysis 
After blocking the Fcγ receptor with anti-mouse CD16/CD32 (2.4G2, BD Biosciences) for 
15mins, the cells were incubated with fluorochrome-conjugated antibody cocktail (Table 1) for 
30mins on the ice. The samples were washed and re-suspended in 200 µL FACS buffer and 
processed for FACS analysis using the FACS CantoII (BD Biosciences). All data were analyzed 
using the FlowJo Software (TreeStar Inc., OR). The gating strategy to detect retinal infiltrating 
immune cells is detailed in our previous publication [10]. 
Real-Time Reverse Transcription-PCR 
The RNeasy Mini Kit (Qiagen, West Sussex, UK) and the TRI Reagent (Sigma-Aldrich) were 
used to extract total RMA from retinal tissue and cell cultures, respectively. The same amount of 
total RNA was used for reverse transcription using the SuperScriptTM II Reverse Transcriptase kit 
(Invitrogen, Paisley, UK) according to the manufacturer’s instructions. The mRNA expression 
levels of different genes were quantified by the real-time reverse transcription-PCR using the 
LightCycler® 480 system with SYBR Green I Master (Roche Diagnostics GmbH, Mannheim, 
Germany). The primers used are listed in Table 2. 18S was used as a housing-keeping gene. 
Murine IL17A and GMCSF mRNA expression levels were determined with LightCycler® 480 
Probe Master (Roche Diagnostics GmbH).  
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Measurement of cytokine and nitric oxide 
Cytokines TNF-α, IL-6, IFN-γ, IL-10, and CCL2 in the supernatants of BMDMs were analyzed 
using cytometric bead array assay (BD Biosciences) according to the manufacturer’s instructions. 
VEGF-a was measured using the DuoSet ELISA kit (R&D Systems). Nitric oxide (NO) 
production in the supernatant was assessed using the Griess Reagent Kit (Life Technologies). 
Data analysis 
All clinical and histological scores were independently graded by two researchers, and the 
averages of the two scores were used as the final scores for statistical analysis. EAU clinical and 
histological scores were analyzed by the Mann-Whitney U test. Retinal whole-mount and cell 
culture data were analyzed by Student’s t-test. Retinal immune cell infiltration and gene 
expression at different time points in WT and LysMCre/+SOCS3fl/fl mice were analyzed by 
two-way ANOVA. All data were presented as mean ± SEM. Probability values of <0.05 were 
considered as statistically significant.  
 
Results 
Retinal inflammation and degeneration in LysMCre/+SOCS3fl/fl EAU mice  
Early retinal inflammation was observed at day 11 p.i. in both WT and LysMCre/+SOCS3fl/fl mice, 
characterized by swelling of the optic disc and vascular cuffing (Fig. 1A). The severity of 
inflammation was increased at day 14, reached peak at day 25 p.i., and then decreased slightly at 
day 60 and 90p.i. (Fig. 1A, B). Inflammatory scores of the LysMCre/+SOCS3fl/fl mice were 
significantly higher than those of WT mice at day 14 p.i. but not at later time points (Fig. 1B). 
Interestingly, the structural damage characterized by linear lesions (Fig. 1A) and retinal atrophy 
(Fig. 1A, C), was more severe in LysMCre/+SOCS3fl/fl EAU mice than that in WT EAU mice. A 
repeated study using C57BL/6 WT, SOCS3fl/fl, and LysMCre/+SOCS3fl/fl mice confirmed that the 
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LysMCre/+SOCS3fl/fl mice suffered from more severe EAU-mediated retinal damage compared to 
WT mice, and there was no difference between SOCS3fl/fl and WT EAU mice (Supplementary 
Figure S1). 
Retinal degeneration was further confirmed by SD-OCT examination. The thickness of 
neuroretina was comparable in non-immunized WT and LysMCre/+SOCS3fl/fl mice. Following 
EAU induction, although the thickness was progressively reduced in both WT and 
LysMCre/+SOCS3fl/fl mice, the reduction was more pronounced in the LysMCre/+SOCS3fl/fl EAU 
mice particularly at day 25 p.i. (Supplementary Figure S2). 
Histological examination showed that cell infiltration in WT and LysMCre/+SOCS3fl/fl mice at day 
25 and day 90 p.i. was comparable (Fig. 1D, 1E). However, the LysMCre/+SOCS3fl/fl EAU mice 
displayed higher levels of structural damage, characterized by the disappearance of 
photoreceptors, disarrangement of retinal layers, and appearance of subretinal/intraretinal scars 
compared to WT EAU mice (Fig. 1D, 1E). Taken together, these results suggest that deletion of 
SOCS3 in myeloid cells resulted in severe retinal degeneration in our model of EAU.  
Early onset of retinal angiogenesis in LysMCre/+SOCS3fl/fl EAU mice  
FFA showed normal retinal vasculature in non-immunized WT and LysMCre/+SOCS3fl/fl mice (Fig. 
2A). Small patches of hyper-fluorescein lesions (an indication of localized severe vascular 
abnormality) were observed at day 60 p.i. WT mice. However, in LysMCre/+SOCS3fl/fl EAU mice, 
similar lesions were observed as early as at day 25 p.i. (Fig. 2A). The number and size of the 
lesion increased as the disease progressed in both WT and LysMCre/+SOCS3fl/fl mice (Figs. 2A, 
2B). Significantly more lesions were observed in LysMCre/+SOCS3fl/fl EAU mice at day 60 and 90 
p.i., compared to WT EAU mice (Figs. 2A, 2B). 
Confocal microscopy of retinal flatmounts detected patches of collagen IV+ lesions that contain 
area of diffuse collagen deposition and new blood vessels (Fig. 2C). The new blood vessels were 
further confirmed by collagen IV and CD105 dual staining (Fig. 2D). The results suggest the 
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fibro-vascular nature of the RNM. The LysMCre/+SOCS3fl/fl EAU mice developed the RNM 
earlier and larger in size compared to WT EAU mice (Fig. 2C, 2D). The data suggest that deletion 
of SOCS3 in myeloid cells resulted in early onset and more severe retinal fibro-vascular 
membrane in EAU.  
Increased neutrophils in the LysMCre/+SOCS3fl/fl EAU mice  
Flow cytometry analysis revealed no difference in the percentage of different subsets of 
leukocytes (CD4, CD8, CD11b, F4/80, CD11b+Gr1+Ly6G+, CD11b+Gr1+Ly6G-) in the blood and 
spleen between non-immunized WT and LysMCre/+SOCS3fl/fl mice (Supplementary Figures S3A, 
S3B). Following induction of EAU, there was a reduction in CD4 and CD8 T cell populations 
and an increase in CD11b, CD11b+Gr1+Ly6G+ (neutrophil), and CD11b+Gr1+Ly6G- MDSC at 
days 25 and 90 p.i., in the blood (Supplementary Figures S3C) and spleen (data not shown) in 
both WT and LysMCre/+SOCS3fl/fl mice. However, significantly higher percentages of neutrophils 
and lower percentages of F4/80+ macrophages were observed in LysMCre/+SOCS3fl/fl EAU mice at 
day 25 p.i. (Supplementary Figures S3C).  
Retinal resident microglia are CD45intCD11b+ and infiltrating leukocytes are CD45hi [10]. EAU 
increased the percentages and the absolute number of microglia and infiltrating leukocytes in 
both WT and LysMCre/+SOCS3fl/fl mice (Figs 3A, 3B). The percentages and absolute numbers of 
microglia and infiltrating leukocytes were comparable in WT and LysMCre/+SOCS3fl/fl EAU mice. 
Further analysis of retinal infiltrating leukocyte subsets showed that the LysMCre/+SOCS3fl/fl EAU 
mice contained more lymphocytes (T/B cells) and less myeloid-derived cells compared to WT 
EAU mice, particularly at day 90 p.i. (Figs. 3C, 3D). Within the myeloid-derived cells, higher 
percentages of neutrophils were observed in the LysMCre/+SOCS3fl/fl EAU retina at both day 25 
and 90 p.i. (Figs. 3C, 3D). These results suggest that deletion of SOCS3 in myeloid cells shifts 
retinal immune infiltration towards lymphocytes and neutrophils in EAU. 
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Inflammatory and angiogenic gene expression in EAU mouse retina 
Under non-inflammatory condition, the LysMCre/+SOCS3fl/fl mouse retina expressed significantly 
higher levels of TNF-α, iNOS, GM-CSF, VEGFa, and Arg-1 compared to WT mouse retina (Fig. 
4A). The expression of IFNγ, IL-17a, IL-10, and IL-6 was below detectable levels in both WT 
and LysMCre/+SOCS3fl/fl mice. After EAU induction, the expression of iNOS, TNF-α, IL-1β, 
GM-CSF, IFN-γ, IL-17a, IL-6, IL-10, CXCL2, and CCL2 was markedly increased at day 25 p.i. 
and remained at high levels throughout the course of the study in both WT and 
LysMCre/+SOCS3fl/fl mice (Fig 4B). The LysMCre/+SOCS3fl/fl EAU retina expressed significantly 
higher levels of TNF-α, IL-1β, GM-CSF, IFN-γ, IL-6, CCL2, CXCL2, and VEGFa compared to 
the WT EAU retina (Fig 4B). Importantly, the expression level of Arg-1 in the 
LysMCre/+SOCS3fl/fl EAU mouse was 49-folds higher than that in WT mouse retina at day 25 p.i. 
(685 ± 218 vs 14 ± 2.7). Retinal whole-mount staining showed that arginase-1 was expressed 
exclusively in infiltrating CD45+ cells (Fig. 4C, 4D), and the percentage of arginase-1+ cells was 
significant higher in LysMCre/+SOCS3fl/fl EAU retina (35%, Fig. 4D) compared to WT EAU retina 
(18%, Fig. 4C). These results suggest that the LysMCre/+SOCS3fl/fl EAU retinas expressed higher 
levels of inflammatory cytokines as well as higher levels of angiogenic growth factors.  
The effects of SOCS3 deletion in bone-marrow–derived macrophages and neutrophils 
Using a standard BMDM culture protocol, similar numbers of F4/80+CD11b+ cells were yielded 
from LysMCre/+SOCS3fl/fl and SOCS3fl/fl mice, suggesting that deletion of SOCS3 in myeloid 
lineage did not affect macrophage differentiation. Naïve SOCS3-deficient BMDMs expressed 
higher levels of IL-1β, VEGFa, and Arg-1 compared to WT cells (Fig. 5A). Following LPS/IFN-γ 
stimulation, the expression of inflammatory genes including TNFA, IL1β, iNOS, and IL6 was 
significantly increased in both SOCS3fl/fl and SOCS3-deficient cells (data not shown). 
Interestingly, higher levels of IL10 mRNA were observed in SOCS3-deficient BMDMs (Fig. 5B). 
IL-4 treatment increased the expression of IL-10, CCL2, VEGF, Ym-1, and Arg-1 in both 
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SOCS3fl/fl and SOCS3-deficient BMDMs (data not shown), although the expression of CCL2 and 
Arg-1 was significantly higher in SOCS3-deficient BMDMs compared to SOCS3fl/fl BMDMs 
(Fig. 5C). Neutrophils from SOCS3-deficient mice expressed significantly higher levels of Arg-1, 
CCL2, and IL-6 compared to those from WT mice (Fig. 5D). The oxidative burst and phagocytic 
activity was also higher in SOCS3-deficient neutrophils (Supplementary figure S4).  
SOCS3-deficient BMDM produced higher levels of VEGF (under non-stimulatory conditions), 
IL-10 (after IFNγ/LPS stimulation), and CCL2 (after IL-4 stimulation) compared to SOCS3fl/fl 
BMDMs (Fig. 5E). The production of TNF-α, IL-6, IFNγ, and NO did not differ between groups 
(Fig. 5E).  
The effect of arginase inhibition in inflammation-induced retinal angiogenesis 
To determine whether the early onset and severe RNM in LysMCre/+SOCS3fl/fl EAU retinas was 
due to enhanced Arg-1 expression, LysMCre/+SOCS3fl/fl EAU mice were treated with an arginase 
inhibitor (ABH) from day 14 to 59 p.i. Although the severity of inflammation remained 
unaffected (Fig. 6A), retinal structure damage (Fig. 6A) and angiogenesis (Fig. 6B) was 
significantly reduced in ABH-treated mice compared to PBS controls.   
The WT EAU mice develop RNM at day 60 p.i., the mice were therefore treated with ABH from 
day 60 ~ 79 p.i. The treatment did not affect the severity of inflammation and structural damage 
(Fig. 6C), but reduced the overall area of RNM (Fig. 6D) and the number localized 
hyper-fluorescein lesion in FFA (Fig. 6E). The results suggest that arginase activity may critically 
contribute to EAU-induced RNM. 
 
Discussion 
This study shows that the deletion of SOCS3 in myeloid cells resulted in severe retinal 
degeneration and an early onset of retinal fibrovascular membrane in EAU. It further shows that 
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the LysMCre/+SOCS3fl/fl EAU retina expressed higher levels of inflammatory cytokines (IL-1β, 
TNFα, and IFNγ) and angiogenic growth factors (VEGF and Arg-1) compared to WT EAU retina. 
Deletion of SOCS3 increased the expression of Arg-1 in macrophages and neutrophils. 
Importantly, it shows that the inhibition of arginase in EAU reduced retinal fibrovascular 
membrane without affecting the severity of inflammation. These results implicate a role for 
SOCS3 in regulating the phenotype and function of myeloid cells in retinal inflammation. 
Retinal degeneration in EAU is primarily caused by antigen-specific T-cell–mediated 
photoreceptor death[27, 28], although inflammatory mediators such as TNF-α, IL-1β, reactive 
oxygen/nitric species (eg, NO) released by infiltrating neutrophils and macrophages also critically 
contribute to retinal cell death [29-31]. The total number of retinal infiltrating cells was comparable 
between WT and LysMCre/+SOCS3fl/fl EAU mice, but the latter displayed more lymphocytes and 
neutrophils and fewer macrophages. Previous studies in EAE [32] and arthritis [33] also reported 
increased neutrophilic infiltration in LysMCre/+SOCS3fl/fl mice. Neutrophil-dominated EAU has 
been observed in the CCL2 or CCR2 knockout mice by us and others [7, 10], although such 
inflammation did not cause more severe retinal degeneration compared to the 
macrophage-dominated EAU in WT mice[7, 10, 34]. The results suggest that the phenotype of 
infiltrating neutrophils may determine the level of retinal damage. The GM-CSF signaling 
pathway critically controls neutrophil differentiation and activation, and is negatively regulated 
by SOCS3[35]. The LysMCre/+SOCS3fl/fl EAU retina expressed higher levels of GM-CSF, and 
neutrophils from these mice expressed more IL-6, CCL2, and Arg-1, and displayed higher levels 
of oxidative burst and increased phagocytosis compared to the cells from WT mice. SOCS3 is 
known to negatively control macrophage phagocytosis and SOCS3 knockdown increases 
macrophage phagocytic activity [36]. Our results suggest that deletion of SOCS3 may lead to 
altered neutrophil/macrophage activation, which may contribute to increased retinal degeneration 
in LysMCre/+SOCS3fl/fl EAU mice.  
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The higher percentages of infiltrating lymphocytes (CD4, CD8, and B cells) may also contribute 
to increased retinal degeneration in the LysMCre/+SOCS3fl/fl EAU mice. T-cell activation in 
autoimmunity is induced by antigen presenting cells, ie, DCs and macrophages, and SOCS3 is 
known to be critically involved in DC differentiation and functions[37, 38]. SOCS3 can regulate 
indoleamine 2,3-dioxygenase expression in DCs[39], which critically controls the balance between 
T-cell activation and tolerance. Over-expression of SOCS3 in DCs suppresses invariant natural 
killer T-cell activation in autoimmune arthritis[40]. However, a previous study reported reduced 
potential to drive T effector cell responses and increased induction of tolerogenic T cells by 
SOCS3 deficient DCs [41], which does not support enhanced autoimmune pathology in the mice 
observed by us and others. How T-cell activation and migration in EAU is affected in 
LysMCre/+SOCS3fl/fl mice warrants further investigation. 
Macrophages are known to play an important role in retinal degeneration and angiogenesis. 
Although the percentage of infiltrating macrophages was lower in LysMCre/+SOCS3fl/fl EAU mice 
compared to that in WT EAU mice, they may be more angioegenic. Macrophage polarization and 
function are regulated by SOCS proteins, particularly SOCS1 and SOCS3 [21, 42]. For example, 
SOCS3 negatively regulates GM-CSF–induced CCL2, Arg-1, and MMP-12 expression in 
BMDMs [43][35]. The higher levels of GM-CSF in LysMCre/+SOCS3fl/fl mouse retina may induce 
CCL2 and Arg-1 expression in macrophages.  
The BMDMs from LysMCre/+SOCS3fl/fl mice appear to have an anti-inflammatory or wound 
healing phenotype bias evidenced by higher levels of IL-10, VEGF, and Arg-1 expression. This 
result is in line with previous SOCS3 knockdown studies [44, 45] and a study in tumor metastasis in 
the LysMCre/+SOCS3fl/fl mouse[46]. However, other studies have shown that deletion of SOCS3 in 
myeloid cells promoted M1 macrophage differentiation, including increased IL-1β, TNFα, iNOS, 
and decreased IL-10 expression [47, 48], although the expression of Arg-1 and VEGF was not 
investigated in those studies. What causes the discrepancy remains unknown. The in vitro 
observation in BMDMs matches the neutrophil data as well as the EAU retina gene expression 
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profile.  
The development of RNM in EAU is related to the shift of infiltrating macrophages from CD68+ 
to Arg-1+ phenotype [7]. At day 25 p.i., the expression of Arg1 mRNA in the LysMCre/+SOCS3fl/fl 
mouse retina was substantially higher than that in the WT mouse retina, and treatment of EAU 
with an arginase inhibitor (ABH) suppressed retinal angiogenesis without affecting the severity of 
inflammation. Macrophages and neutrophils from LysMCre/+SOCS3fl/fl mice expressed 
significantly higher levels of Arg-1 and VEGF compared to those from WT mice. Arginase 
catalyzes the conversion of arginine to ornithine, a precursor of polyamines and collagen, thus 
contributing to the production of extracellular matrix that supports angiogenesis[50]. Arginase is 
known to play an important role in regulating inflammation and is involved in vascular 
complications of retinal disease, including diabetic retinopathy[51, 52] and choroidal 
neovascularization[53]. Our results highlight the role of Arg-1 as an important angiogenic 
mediator under inflammatory conditions.  
The early onset of RNM in the LysMCre/+SOCS3fl/fl mice is in line with the previous observation 
in the laser-induced choroidal neovascularization in these mice [49], where a link between STAT3 
activation in circulating immune cells and neovascular age-related macular degeneration was 
reported. The role of the SOCS3-STAT3 pathway in retinal inflammation and angiogenesis has 
been observed in a number of studies. Sun et al showed that SOCS3 in retinal neurons and glial 
cells suppressed VEGF signalling to prevent pathological neovascular growth in mouse model of 
oxygen-induced retinopathy [54]. Ozawa et al reported enhanced retinal inflammation and 
photoreceptor degeneration in retina-specific SOCS3 KO mice following LPS stimulation [55]. 
Further understanding the role of the SOCS3-STAT3 pathway in retinal health and disease may 
uncover novel target for therapy.  
In summary, our study suggests that SOCS3 critically controls the phenotype and functions of 
macrophages and neutrophils under inflammatory conditions. In the absence of SOCS3, 
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macrophages and neutrophils express higher levels of Arg-1, CCL2, IL-6, and VEGF and 
promote angiogenesis. SOCS3 deficiency also enhances phagocytosis and oxidative bursts in 
neutrophils, which may contribute to exacerbated retinal degeneration in EAU. Targeting SOCS3 
may be a novel approach to control inflammation and its related angiogenesis.   
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Figure legends 
Figure 1. Retinal inflammation in WT and LysMCre/+SOCS3fl/fl experimental autoimmune 
uveoretinitis (EAU) mice. EAU was induced in WT and LysMCre/+SOCS3fl/fl mice and clinical 
inflammation was examined by fundus imaging at different days after immunization, and 
histology was conducted on day 25 and 90 post-immunization (p.i.). A: Fundus images from WT 
and LysMCre/+SOCS3fl/fl mice on different days after immunization. OD - optic disc; arrows – 
retinal infiltrates; arrowheads – vascular cuffings. B: Clinical score of retinal inflammation. C: 
Clinical score of retinal structure damage at different stages of EAU. N = 6~12, *P < 0.05. Mann 
Whitney test. D: Representative images of H&E staining of EAU retina from WT and 
LysMCre/+SOCS3fl/fl mice. Small arrows – retinal fulds; large arrows – fibrotic lesions; asterisk – 
granular lesion. Scale bar = 50 µm. E, F: Histological scores on retinal immune cell infiltration 
and structure damage in WT and LysMCre/+SOCS3fl/fl EAU mice. N = 6, *P < 0.05 compared to 
WT mice. Mann Whitney test.  
 
Figure 2. Retinal fibrovascular membrane in WT and LysMCre/+SOCS3fl/fl experimental 
autoimmune uveoretinitis (EAU) mice. EAU was induced in WT and LysMCre/+SOCS3fl/fl mice 
and fluorescein angiography (FA) was conducted at different days after immunization. A: 
Representative FA images from WT and LysMCre/+SOCS3fl/fl mice on different days after 
immunization. Arrows indicate the hyper-fluorescent lesions. Scale bar = 500 µm. B: The number 
of hyper-fluorescent lesions per eye in each groups at different times. C: Confocal image from a 
day 60 p.i. WT EAU retina stained for collagen IV showing new blood vessels (arrows) and 
collagen deposition (asterisk) around a diseased venule. Scale bar = 50 µm. D: Confocal image 
from a retinal section from a day 90 p.i. WT EAU retina stained for collagen IV (green) and 
CD105 (red) showing multiple vessels (arrows) in retinal fibrovascular membrane. E, F: Retinal 
flatmounts from day 25 and 90 p.i., EAU mice were stained for collagen IV, and imaged by 
confocal microscopy. Scale bar = 25µm. E: Representative images of retinal flatmounts from WT 
and LysMCre/+SOCS3fl/fl  mice showing retinal vasculature and neovascular membrane (arrows). 
F: The size of retinal neovascular membrane in WT and LysMCre/+SOCS3fl/fl mice at day 25 and 
90 p.i. N = 6 ~ 8, *P < 0.05 compared to WT mice at the same time point. 
 
Figure 3. The constitution of immune cells in WT and LysMCre/+SOCS3fl/fl experimental 
autoimmune uveoretinitis (EAU) retina. Retinas from days 25 and 90 p.i. WT and SOCS3 KO 
mice were collected. Single-cell suspension was prepared (Materials and Methods) and stained 
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for different cell-surface markers and analyzed by flow cytometry. A: The percentage and number 
of retinal microglia cells in different stages of EAU in WT and LysMCre/+SOCS3fl/fl mice. B: The 
percentage and number of retinal infiltrating cells in different stages of EAU in WT and 
LysMCre/+SOCS3fl/fl mice. Data are presented as mean ± SEM. N = 3. C, D: Pie charts showing 
the percentages of macrophages (F4/80+), neutrophils (CD11+Gr-1+Ly6G+), DCs (CD11c+), 
MDSCs (CD11b+Gr-1+Ly6G-), B cells (B220+), and CD4+ and CD8+ cells in WT and SOCS3 KO 
EAU retinas at days 25 (C) and 90 (D) p.i. Data in pie charts are the means of three mice. *P < 
0.05; **P < 0.01, ***P < 0.001 compared to WT mice at the same time point.  
Figure 4. Inflammatory gene expression in the retina in WT and LysMCre/+SOCS3fl/fl mice. 
Total RNA of WT and LysMCre/+SOCS3fl/fl mouse retina was extracted and cDNA was 
synthesized for real-time PCR. A: Messenger RNA expression of chemokines TNF, iNOS 
(official name ISNYA1), GMCSF (official name CSF2), VEGFA, and Arg1 genes in normal WT 
and SOCS3 KO mice. B: mRNA expression of TNF, IL1B, iNOS, GM-CSF, IFNG, IL17A, IL6, 
CCL2, CXCL2, VEGFA, IL10, and Arg1 genes at different stages of EAU in WT and SOCS3 KO 
mice. The results shown are gene fold-change compared with WT non-immunized control retina. 
Data are presented as Mean ± SEM. N = 6. *P < 0.05, **P < 0.01, ***P < 0.001 compared with 
SOCS3 KO mouse retina at the same time point. Two-way ANOVA with Bonferroni post-tests. C, 
D: Retinal flatmounts from day 60 p.i. EAU of WT (C) and LysMCre/+SOCS3fl/fl mice stained for 
CD45 (green) and arginase-1 (red) and imaged by confocal microscopy. Scale bar = 50 µm.  
Figure 5. Immune gene expression and protein secretion in bone-marrow–derived 
macrophages (BMDMs) and neutrophils from SOCS3fl/fl and LysMCre/+SOCS3fl/fl mice. 
BMDMs were cultured from SOCS3fl/fl and SOCS3 KO mice and netrophils were isolated from 
bone marrow of these mice. Total RNA was extracted from the cells and cDNA was synthesized 
for real-time PCR. A-C: Immune gene expression in naïve non-poloarized M0 (B), LPS/IFNγ (B), 
or IL-4 (C) treated macrophages from SOCS3fl/fl and SOCS3 KO mice. D: Immune gene 
expression in bone-marrow–derived neutrophils from WT and SOCS3 KO mice. Data presented 
are gene fold-changes in cells from SOCS3 KO mice compared to that from SOCS3fl/fl mice 
under the same treatment conditions. N = 3, *P < 0.05. E: The protein levels in the supernatants 
of BMDMs from SOCS3fl/fl and SOCS3 KO mice under different polarization conditions. Data 
are presented as Mean ± SEM. N = 6. *P < 0.05; **P < 0.01. Unpaired student’s t-test. 
Figure 6. The effects of amino-2-borono-6-hexanoic (ABH) on experimental autoimmune 
uveoretinitis (EAU)-induced retinal angiogenesis in WT and LysMCre/+SOCS3fl/fl mice. A, B: 
LysMCre/+SOCS3fl/fl EAU mice were treated with 200 µM ABH (i.p.) or PBS once daily from day 
14 to 60 p.i. A: Clinical score of inflammation and structural damage at days 14, 40, and 60 p.i. B: 
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Representative confocal images of retinal flatmounts from day 60 p.i. and the number of retinal 
neovascular membrane (RNM) in PBS- and ABH-treated SOCS3 KO mice. C-E: WT EAU mice 
were treated with 200 µM ABH (i.p.) or PBS once daily from day 60 to 79 p.i. C: Clinical score 
of inflammation and structural damage were evaluated at days 25, 60, and 80 p.i. D: 
Representative confocal images of retinal flatmounts from day 80 p.i. and the number of RNM in 
PBS- and ABH-treated EAU KO mice. E: Fluorescent angiography showing hyper-fluorescent 
lesions in PBS- and ABH-treated EAU mice and the average number of hyper-fluorescent lesions. 
Mean ± SEM, N = 5~6 mice, *P < 0.05, **P < 0.01 compared to PBS-treated group.  
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Table 1. Antibodies used in flow cytometry. 
Target 
molecule 
Conjugated 
fluorochrome 
Origin Clone Company 
CCR2 APC Rat 475301 R&D Systems 
CD8a APC-Cy7  Rat 53-6.7 BD Biosciences 
Ly6G APC-Cy7 Rat 1A8 BD Biosciences 
CX3CR1 Alexa Fluor 488 Goat (Polyclonal) R&D Systems 
CD4 Pacific blue  Rat RM4-5 BD Biosciences 
I/A I/E eF450 Rat M5/114.15.2 eBiosciences 
F4/80  PE Rat CI:A3-1 Serotec 
Gr-1 PE Rat RB6-8C5 BD Biosciences 
CD11c PE Hamster HL3 BD Biosciences 
CD86 PE Rat GL1 BD Biosciences 
CD11b PE-Cy7 Rat M1/70 BD Biosciences 
CD45 PerCP Rat 30-F11 BD Biosciences 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
28 
 
Table 2. Primers used in real-time reverse transcription-PCR. 
Targets Annealing 
temperature 
(oC) 
Sequences 
18S 58 Forward 
Reverse 
5’– AGGGGAGAGCGGGTAAGAGA – 3’ 
5’–GGACAGGACTAGGCGGAACA–3’ 
Arg-1 61 Forward 
Reverse 
5 – TTATCGGAGCGCCTTTCTCAA–3’ 
5’–TGGTCTCTCACGTCATACTCTGT–3’ 
CCL2 58 Forward 
Reverse 
5’–AGGTCCCTGTCATGCTTCTG–3’ 
5’–TCTGGACCCATTCCTTCTTG–3’ 
CXCL2 58 Forward 
Reverse 
5’–AAGTTTGCCTTGACCCTGAA–3’ 
5’–AGGCACATCAGGTACGATCC–3’ 
IFN-γ 56 Forward 
Reverse 
5’–GCTCTGAGACAATGAACGCT–3’ 
5’–AAAGAGATAATCTGGCTCTGC–3’ 
IL-1β 58 Forward 
Reverse 
5’–TCCTTGTGCAAGTGTCTGAAGC–3’ 
5’–ATGAGTGATACTGCCTGCCTGA–3’ 
IL-10 58 Forward 
Reverse 
5’–TGCAGGACTTTAAGGGTTACTTGG–3’ 
5’–GGCCTTGTAGACACCTTGGTC–3’ 
IL-6 58 Forward 
Reverse 
5’–TCTGCAAGAGACTTCCATCCAGT–3’ 
5’ –TCTGCAAGTGCATCATCGTTGT–3’ 
iNOS 58 Forward 
Reverse 
5’–GGCAAACCCAAGGTCTACGTT–3’ 
5’–TCGCTCAAGTTCAGCTTGGT–3’ 
TNF-α 58 Forward 
Reverse 
5’–GCCTCTTCTCATTCCTGCTT–3’ 
5’–CTCCTCCACTTGGTGGTTTG–3’ 
VEGF-A 58 Forward 
Reverse 
5’–CCCACGTCAGAGAGCAACAT–3’ 
5’–TTTCTTGCGCTTTCGTTTTT–3’ 
Ym-1 58 Forward 
Reverse 
5’–ACTTTGATGGCCTCAACCTG–3’ 
5’–AATGATTCCTGCTCCTGTGG–3’ 
TGF-β 58 Forward 
Reverse 
5’–GTGTGGAGCAACATGTGGAACT–3’ 
5’–GGGCTGATCCCGTTGATTTC–3’ 
IL-17a(Il17a*)   Mm00439618_m1 
GM-CSF 
(Csf2)* 
  Mm01290062_m1 
*Gene expression was conducted using the LightCycler® 480 Probe Master from Roche 
Diagnostics GmbH. 
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